PLANNED VISUAL EDUCATION ABOUT SKIN CANCER

June 13, 2023 updated by: Celal Bayar University

DOES PLANNED VISUAL EDUCATION AFFECT UNIVERSITY STUDENTS' ATTITUDES AND BELIEFS ABOUT SKIN CANCER?

This study aimed to evaluate the effect of planned visual education based on the Health Belief Model on university students' attitudes and beliefs toward skin cancer. The planned visual education based in Health Belief Model has possitive effects on univestiy students' attitudes and beliefs toward skin cancer.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This study aimed to evaluate the effect of planned visual education based on the Health Belief Model on university students' attitudes and beliefs toward skin cancer. Planned as a cluster-randomized controlled experimental study conducted on two groups (n=116). The study was carried out in Faculty of Economics and Administrative Sciences (FEAS) and Hasan Ferdi Turgutlu Faculty of Technology (HFTFT) from the faculties of Manisa Celal Bayar University (MCBU) between February-Semptember 2019. Among seven departments in FEAS and four departments in the HFTFT, simple random sampling was used to draw lots again. The Department of Econometrics from the FEAS was assigned as the intervation groups (n=58) and Mechatronics Engineering from HFTFT was assigned as the control group (n=58). Data were collected using The Student Introduction Form and The Health Belief Model Scale in Skin Cancer.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
116

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Manisa, Turkey
        • CelalBayarU

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years to 24 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • who Registered and continuing department courses
  • who agreed to participate in the study
  • who had formal education
  • who been second year students

Exclusion Criteria:

  • Registration and absence of the student in the department courses
  • Refusal to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: intervention group
The sample of this cluster randomized controlled experimental study consisted of 2nd year university students (n=116) training in Faculty of Economics and Administrative Sciences (FEAS) and Hasan Ferdi Turgutlu Faculty of Technology (HFTFT) from the faculties of Manisa Celal Bayar University (MCBU) between February-Semptember 2019. Among the faculties in MCBU, simple random sampling was used to draw lots, with the first lot being assigned to FEAS as the intervention group (IG), and the second lot being assigned to HFTFT as the control group (CG) . Among seven departments in FEAS and four departments in the HFTFT, simple random sampling was used to draw lots again. The Department of Econometrics from the FEAS was assigned as the IG and Mechatronics Engineering from HFTFT was assigned as the CG. The planned visual education based Health Belief Model was given.
Other: Planned Visual Education Based on Health Belief Model

The students in IG were administered the planned visual education based on Health Belief Model for a period of seven months.

The education materials were a PowerPoint presentation, a skin cancer model, videos titled "Dear 16 years old me", "Mr. Sun", a brochure, and 3 posters.

.
No Intervention: Control group
No attempt was made by researcher during the study. Only data were collected. At the end of the study, the planned visual education based Health Belief Model was given and all students continued in the study were given key rings with pictures about sun protection designed by the researchers.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
The Health Belief Model Scale in Skin Cancer
Time Frame: One months
Developed by Dogan and Caydam (2021), the scale consists of 26 items and 5 sub-dimensions (perceived susceptibility, perceived benefit, perceived severity, perceived barriers, and self-efficacy). The HBMSSC is a five-point Likert-type scale, and each item is answered from "disagree=1" to "strongly agree=5". The total Cronbach's alpha coefficient of the scale is 0.86, and for the sub-dimensions it is 0.89; 0.79; 0.77; 0.65 and 0.86, respectively. The "perceived barriers" sub-dimension of the scale is reverse coded. The scale does not have a total score, and each sub-dimension is scored within itself. Higher "perceived susceptibility, "perceived benefit, "perceived severity", and "self-efficacy" scores indicate higher perceived susceptibility, perceived benefit, perceived severity, and self-efficacy
One months
The Health Belief Model Scale in Skin Cancer
Time Frame: Three months
Developed by Dogan and Caydam (2021), the scale consists of 26 items and 5 sub-dimensions (perceived susceptibility, perceived benefit, perceived severity, perceived barriers, and self-efficacy). The HBMSSC is a five-point Likert-type scale, and each item is answered from "disagree=1" to "strongly agree=5". The total Cronbach's alpha coefficient of the scale is 0.86, and for the sub-dimensions it is 0.89; 0.79; 0.77; 0.65 and 0.86, respectively. The "perceived barriers" sub-dimension of the scale is reverse coded. The scale does not have a total score, and each sub-dimension is scored within itself. Higher "perceived susceptibility, "perceived benefit, "perceived severity", and "self-efficacy" scores indicate higher perceived susceptibility, perceived benefit, perceived severity, and self-efficacy
Three months
The Health Belief Model Scale in Skin Cancer
Time Frame: Seven months
Developed by Dogan and Caydam (2021), the scale consists of 26 items and 5 sub-dimensions (perceived susceptibility, perceived benefit, perceived severity, perceived barriers, and self-efficacy). The HBMSSC is a five-point Likert-type scale, and each item is answered from "disagree=1" to "strongly agree=5". The total Cronbach's alpha coefficient of the scale is 0.86, and for the sub-dimensions it is 0.89; 0.79; 0.77; 0.65 and 0.86, respectively. The "perceived barriers" sub-dimension of the scale is reverse coded. The scale does not have a total score, and each sub-dimension is scored within itself. Higher "perceived susceptibility, "perceived benefit, "perceived severity", and "self-efficacy" scores indicate higher perceived susceptibility, perceived benefit, perceived severity, and self-efficacy
Seven months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Celal Bayar University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
February 1, 2019

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
September 20, 2019

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
September 30, 2019

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
March 2, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 16, 2023

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
March 29, 2023

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
June 15, 2023

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 13, 2023

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
June 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 2018-186

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

ll IPD that underlie results in a publication

IPD Sharing Time Frame

starting 6 months after publication

IPD Sharing Access Criteria

It can be shared upon request, if the relevant ethics committee approves.

IPD Sharing Supporting Information Type

  • CSR

Study Data/Documents

  1. Informed Consent Form
    Information comments: Dogan ES, Caydam OD. Investigation of Studies Conducted with Health Belief Model in Skin Cancer. Izmir Democracy University Health Sciences Journal.2019; 2(2):66-75.
  2. Statistical Analysis Plan
    Information comments: Dogan ES, Caydam OD. A Scale Development Study: Health Belief Model Scale in Skin Cancer among Turkish University Students. Saudi Journal of Nursing and Health Care. 2021; 4(8): 205- 213. https://doi.org/10.36348/sjnhc.2021.v04i08.001.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings